In the Era of mpMRI and PSMA PET/CT: Does Digital Rectal Examination Still Matter?
The Prostate · 2026
DOI: 10.1002/pros.70151 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2026. Verfasst von Anil Eker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Izmir City Hospital, Izmir, Turkey. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Digital Rectal Examination, Multiparametric Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
With the increasing integration of multiparametric MRI (mpMRI) and 68Ga‐PSMA PET/CT into the diagnostic and staging algorithms of prostate cancer (PCa), digital rectal examination (DRE)—a once foundational and cost‐effective physical examination—has gradually become marginalized in daily clinical practice. However, the continued relevance of DRE in the modern imaging era remains uncertain. This study aimed to reassess the diagnostic value of DRE in the context of contemporary imaging tools, particularly mpMRI and PSMA PET/CT.
Methods
This retrospective analysis included 164 patients diagnosed with prostate adenocarcinoma via transrectal ultrasound‐guided biopsy. All patients underwent DRE before biopsy, and 151 received mpMRI while 62 underwent PSMA PET/CT. mpMRI findings were reported using PI‐RADS v2.1, and SUVmax values were recorded from PET/CT reports. Radical prostatectomy was performed in 156 patients. The relationship between DRE findings and imaging parameters, biopsy results, and pathological staging was analyzed using multivariate statistics and ROC curve analyses.
Results
DRE findings were benign in 100 patients and suspicious for malignancy in 64. Suspicious DRE was significantly associated with higher PI‐RADS scores, greater lesion size, elevated SUVmax, and clinically significant PCa ( p < 0.001 for all). Each one‐point increase in PI‐RADS was associated with a twofold rise in the likelihood of a positive DRE. ROC analyses identified a 13.5 mm lesion size and an SUVmax of 15.1 as predictive thresholds for DRE positivity. Suspicious DRE also correlated with advanced pathological stage (≥ pT3) ( p < 0.001).
Conclusion
Despite the rise of advanced imaging techniques, DRE remains a valuable adjunctive tool in identifying high‐risk and advanced PCa. When interpreted alongside mpMRI and PSMA PET/CT findings, DRE provides additional clinical insight, supporting its continued role in risk stratification rather than screening in the modern diagnostic workflow.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Izmir City Hospital, Izmir, Turkey.
- Department of Urology, Izmir City Hospital, University of Health Sciences, Izmir, Turkey.
- Department of Nuclear Medicine, Izmir City Hospital, Izmir, Turkey.
- Department of Radiology, Izmir City Hospital, Izmir, Turkey.
- Department of Urology, Izmir Faculty of Medicine, University of Health Sciences, Izmir, Turkey.
ORCID-Profile: Anil Eker, Selda Yilmaz Tatar, Ebru Hasbay, Berk Karaca, Mahmut Cinar, Yasin Ceylan, Deniz Bolat, Tansu Degirmenci, Serdar Celik
Zitieren
APA
Eker, A., Diler, F., Tatar, S. Y., Hasbay, E., Kayar, C., Karaca, B., Cinar, M., Ceylan, Y., Bolat, D., Degirmenci, T., & Celik, S. (2026). In the Era of mpMRI and PSMA PET/CT: Does Digital Rectal Examination Still Matter?. The Prostate. https://doi.org/10.1002/pros.70151
Vancouver
Eker A, Diler F, Tatar SY, Hasbay E, Kayar C, Karaca B, et al. In the Era of mpMRI and PSMA PET/CT: Does Digital Rectal Examination Still Matter?. The Prostate. 2026. doi:10.1002/pros.70151
BibTeX
@article{Eker2026,
author = {Eker, Anil and Diler, Fatih and Tatar, Selda Yilmaz and Hasbay, Ebru and Kayar, Cagatay and Karaca, Berk and Cinar, Mahmut and Ceylan, Yasin and Bolat, Deniz and Degirmenci, Tansu and Celik, Serdar},
title = {In the Era of mpMRI and PSMA PET/CT: Does Digital Rectal Examination Still Matter?},
journal = {The Prostate},
year = {2026},
doi = {10.1002/pros.70151}
}
EUVIMED